CXCL9 and metastatic malignant neoplasm in the lymph nodes: Further analyses showed that CXCL9 was lowly expressed in patients with more lymph node metastasis according to density in both TC and IM (p = 0.018), percentage quantification in TC (p = 0.043), and percentage quantification in both TC and IM (p = 0.036).